Thiol Disulfide Balance and Oxidative Stress Change in Endometrial Polyp Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06826495

Enrollment

Registered

2025-02-14

Start date

2021-01-02

Completion date

2022-01-05

Last updated

2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Polyp, Oxidative Stress

Brief summary

Changes in Thiol Disulfide Balance and Oxidative Stress Mechanisms in Patients with Endometrial Polyps

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 48 Years

Healthy volunteers

Inclusion criteria

For participants in the control group: • To be without endometrial polyp For the polyp group, they were as follows: * Individuals experiencing menometrorrhagia * A body mass index (BMI) of 25 or more * Hypertension * Endometrial polyps detected via saline infusion ultrasonography

Exclusion criteria

* Pregnancy * Diabetes mellitus * Pelvic mass * Malignancy * The use of Tamoxifen, hormonal contraceptives, or hormone replacement therapy.

Design outcomes

Primary

Measure	Time frame	Description
Oxidative stress markers	From January 2021 to January 2022	Total antioxidant status (μmol Trolox equivalent/ L)

Countries

Turkey (Türkiye)

Outcome results